Efficacy and safety of levofloxacin in the outpatient treatment of exacerbation of chronic obstructive pulmonary disease: levofloxacin 750 mg vs. levofloxacin 500 mg

Journal
Health and Primary Care
Date Issued
2020
Author(s)
Petrova, T
DOI
10.15761/hpc.1000184
Subjects

bacterial exacerbatio...

chronic obstructive p...

clinical success rate...

levofloxacin

relaps

side effects

File(s)
Loading...
Thumbnail Image
Name

Efficacy and safety of levofloxacin in the outpatient treatment of exacerbation of COPD levofloxacin 750 vs 500 mg_HPC-4-184.pdf

Size

331.14 KB

Format

Adobe PDF

Checksum

(MD5):e1e18e2e49165888e44a32b3cd02448d